Kevin C. Gorman
2015
In 2015, Kevin C. Gorman earned a total compensation of $5M as President and Chief Executive Officer at Neurocrine Biosciences, a 16% decrease compared to previous year.
Compensation breakdown
| Bonus | $345,000 |
|---|---|
| Option Awards | $3,225,000 |
| Salary | $575,000 |
| Stock Awards | $824,750 |
| Other | $42,217 |
| Total | $5,011,967 |
Gorman received $3.2M in option awards, accounting for 64% of the total pay in 2015.
Gorman also received $345K in bonus, $575K in salary, $824.8K in stock awards and $42.2K in other compensation.
Rankings
In 2015, Kevin C. Gorman's compensation ranked 1,587th out of 13,638 executives tracked by ExecPay. In other words, Gorman earned more than 88.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,587 out of 13,638 | 88th |
Division Manufacturing | 574 out of 5,187 | 89th |
Major group Chemicals And Allied Products | 210 out of 1,857 | 89th |
Industry group Drugs | 161 out of 1,531 | 90th |
Industry Biological Products, Except Diagnostic Substances | 26 out of 260 | 90th |
Source: SEC filing on April 20, 2017.
Gorman's colleagues
We found four more compensation records of executives who worked with Kevin C. Gorman at Neurocrine Biosciences in 2015.
News
Neurocrine Biosciences CEO Kevin Gorman's 2021 pay rises 1% to $14M
April 7, 2022
Neurocrine Biosciences CEO Kevin Gorman's 2020 pay jumps 47% to $14M
April 9, 2021
Neurocrine Biosciences CEO Kevin Gorman's 2019 pay rises 9% to $9.5M
April 9, 2020
Neurocrine Biosciences CEO Kevin Gorman's 2018 pay rises 14% to $8.6M
April 17, 2019